BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10432936)

  • 1. Cytogenetic investigation of chordomas of the skull.
    Buonamici L; Roncaroli F; Fioravanti A; Losi L; Van den Berghe H; Calbucci F; Dal Cin P
    Cancer Genet Cytogenet; 1999 Jul; 112(1):49-52. PubMed ID: 10432936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of three variants of clival chordoma.
    Gil Z; Fliss DM; Voskoboinik N; Leider-Trejo L; Spektor S; Yaron Y; Orr-Urtreger A
    Cancer Genet Cytogenet; 2004 Oct; 154(2):124-30. PubMed ID: 15474147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications.
    Mitchell A; Scheithauer BW; Unni KK; Forsyth PJ; Wold LE; McGivney DJ
    Cancer; 1993 Nov; 72(10):2943-9. PubMed ID: 7693324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilaginous tumors and chordomas of the cranial base.
    Weber AL; Brown EW; Hug EB; Liebsch NJ
    Otolaryngol Clin North Am; 1995 Jun; 28(3):453-71. PubMed ID: 7675464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
    Rosenberg AE; Brown GA; Bhan AK; Lee JM
    Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
    Huse JT; Pasha TL; Zhang PJ
    Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cytogenetic abnormalities on the management of skull base chordomas.
    Almefty KK; Pravdenkova S; Sawyer J; Al-Mefty O
    J Neurosurg; 2009 Apr; 110(4):715-24. PubMed ID: 19133754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chordomas of the skull base. Radiologic and clinical evaluation.
    Weber AL; Liebsch NJ; Sanchez R; Sweriduk ST
    Neuroimaging Clin N Am; 1994 Aug; 4(3):515-27. PubMed ID: 7952953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and ultrastructural study of skull base chordomas.
    Kubota T; Sato K; Kabuto M; Kawano H; Nakagawa T; Arai Y; Tachibana O; Yoshida K; Yamashita J
    Noshuyo Byori; 1994; 11(1):23-8. PubMed ID: 7512866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroid chordoma. A hyalinized chordoma without cartilaginous differentiation.
    Jeffrey PB; Biava CG; Davis RL
    Am J Clin Pathol; 1995 Mar; 103(3):271-9. PubMed ID: 7532910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
    Eisenberg MB; Woloschak M; Sen C; Wolfe D
    Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
    Pamir MN; Ozduman K
    Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of myxoid bone tumors of the skull base].
    Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
    Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological and immunohistochemical study of 34 cases of chordoma].
    Hu Y; Gao Y; Zhang X
    Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):142-4. PubMed ID: 9275666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.
    Vuong HG; Dunn IF
    World Neurosurg; 2022 Jun; 162():e635-e639. PubMed ID: 35339711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: can immunohistochemistry resolve the controversy?
    Ishida T; Dorfman HD
    J Neurooncol; 1994; 18(3):199-206. PubMed ID: 7525890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroid chordoma: fine-needle aspiration cytology with histopathological, immunohistochemical, and ultrastructural study of two cases.
    Moriki T; Takahashi T; Wada M; Ueda S; Ichien M; Miyazaki E
    Diagn Cytopathol; 1999 Nov; 21(5):335-9. PubMed ID: 10527481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.